Case-Based Review

A case of statin-associated immune-mediated necrotizing myopathy with atypical biopsy features

Volume 8 · Issue 1 Publish Date: January 1, 2021
Full Text PDF
DOI
Mark M. Zaki
Department of Medicine, Harvard Medical School, Boston, MA, USA
Zain M. Virk
Department of Medicine, Harvard Medical School, Boston, MA, USA
Diego Lopez
Department of Medicine, Harvard Medical School, Boston, MA, USA
Jenna Klubnick
Department of Medicine, Harvard Medical School, Boston, MA, USA
Jared T. Ahrendsen
Department of Medicine, Harvard Medical School, Boston, MA, USA
Hemant Varma
Department of Medicine, Harvard Medical School, Boston, MA, USA
Vasileios Kyttaris
Department of Medicine, Harvard Medical School, Boston, MA, USA
Ilana Abeles
Department of Medicine, Harvard Medical School, Boston, MA, USA
Zaki, M. M., Virk, Z. M., Lopez, D., Klubnick, J., Ahrendsen, J. T., Varma, H., … Abeles, I. (2021). A case of statin-associated immune-mediated necrotizing myopathy with atypical biopsy features. European Journal of Rheumatology, 8(1), 36–39. https://doi.org/10.5152/eurjrheum.2020.20064
Full Text Full Text PDF

Abstract

Statin-associated immune-mediated necrotizing myopathy (IMNM) is a rare presentation of a statin-associated myopathy. Patients usually present with muscle weakness and pain in the setting of statin use with elevated creatine kinase (CK) levels and a positive anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody. Muscle biopsies typically show necrosis, CD68+ macrophages, and minimal lymphocytes. We present a case of a 67-year-old woman who had 2 months of progressive weakness and bilateral lower extremity pain after initiating atorvastatin therapy with symptoms persisting after statin cessation. She was found to have high anti-HMGCR antibody titers, and the biopsy of the rectus femoris muscle showed a prominent endomysial inflammatory cell infiltrate with necrotic and regenerative fibers and an atypical extensive inflammatory infiltrate composed of both CD4+ helper T cells and CD8+ cytotoxic T cells. She showed symptom resolution and normalization of CK levels and inflammatory markers with treatment involving a prolonged prednisone taper and a brief course of azathioprine, which was stopped because of the adverse effects.

Cite this article as: Zaki MM, Virk ZM, Lopez D, Klubnick J, Ahrendsen JT, Varma H, et al. A case of statin-associated immune-mediated necrotizing myopathy with atypical biopsy features. Eur J Rheumatol 2021; 8(1): 36-9.

Article Info
Published In
Journal European Journal of Rheumatology
Volume / Issue Volume 8 · Issue 1
Pages 36-39
History
Published Online January 1, 2021
Copyright
Affiliations
Mark M. Zaki
Department of Medicine, Harvard Medical School, Boston, MA, USA
Zain M. Virk
Department of Medicine, Harvard Medical School, Boston, MA, USA
Diego Lopez
Department of Medicine, Harvard Medical School, Boston, MA, USA
Jenna Klubnick
Department of Medicine, Harvard Medical School, Boston, MA, USA
Jared T. Ahrendsen
Department of Medicine, Harvard Medical School, Boston, MA, USA
Hemant Varma
Department of Medicine, Harvard Medical School, Boston, MA, USA
Vasileios Kyttaris
Department of Medicine, Harvard Medical School, Boston, MA, USA
Ilana Abeles
Department of Medicine, Harvard Medical School, Boston, MA, USA
Cite this Article
Zaki, M. M., Virk, Z. M., Lopez, D., Klubnick, J., Ahrendsen, J. T., Varma, H., … Abeles, I. (2021). A case of statin-associated immune-mediated necrotizing myopathy with atypical biopsy features. European Journal of Rheumatology, 8(1), 36–39. https://doi.org/10.5152/eurjrheum.2020.20064
Share
Outlines